Access the full text.
Sign up today, get DeepDyve free for 14 days.
I. Fenic, V. Sonnack, K. Failing, M. Bergmann, K. Steger (2004)
In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis.Journal of andrology, 25 5
A Loboda, VR Fantin, SS Randolph, M Flynn, EJ Friedman, JL Ricker, JS Hardwick, VM Richon, M Iwamoto, SR Frankel, JA Wagner, EH Rubin (2007)
Vorinostat (suberoylanilide hydroxamic acid, SAHA) induces robust gene expression changes in peripheral blood mononuclear cells from patients with solid tumors, consistent with its effects in panels of human tumor cell lines, 48
Haibin Wang, S. Dey (2006)
Roadmap to embryo implantation: clues from mouse modelsNature Reviews Genetics, 7
H. Uchida, T. Maruyama, T. Arase, M. Ono, T. Nagashima, H. Masuda, H. Asada, Y. Yoshimura (2005)
Historie acetylation in reproductive organs: Significance of histone deacetylase inhibitors in gene transcriptionReproductive Medicine and Biology, 4
M. Freeman (2006)
CHAPTER 43 – Neuroendocrine Control of the Ovarian Cycle of the Rat
PA Marks, T Miller, VM Richon (2003)
Histone deacetylases, 3
E. Menegola, F. Renzo, M. Broccia, E. Giavini (2006)
Inhibition of histone deacetylase as a new mechanism of teratogenesis.Birth defects research. Part C, Embryo today : reviews, 78 4
Haengseok Song, H. Lim, B. Paria, H. Matsumoto, L. Swift, J. Morrow, J. Bonventre, S. Dey (2002)
Cytosolic phospholipase A2α deficiency is crucial for 'on-time' embryo implantation that directs subsequent developmentDevelopment, 129
J Song, H Lim, BC Paria, H Matsumoto, LL Swift, J Morrow, JV Bonventre, SK Key (2002)
Cytosolic phospholipase A2α is crucial for ‘on‐time’ embryo implantation and directs subsequent development, 129
Ying Zhang, M. Dufau (2003)
Dual mechanisms of regulation of transcription of luteinizing hormone receptor gene by nuclear orphan receptors and histone deacetylase complexesThe Journal of Steroid Biochemistry and Molecular Biology, 85
Wen‐Ming Yang, Ya-Li Yao, Jian‐Min Sun, J. Davie, E. Seto (1997)
Isolation and Characterization of cDNAs Corresponding to an Additional Member of the Human Histone Deacetylase Gene Family*The Journal of Biological Chemistry, 272
X. Ye, K. Hama, J. Contos, B. Anliker, A. Inoue, M. Skinner, Hiroshi Suzuki, T. Amano, Grace Kennedy, H. Arai, J. Aoki, J. Chun (2005)
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacingNature, 435
Kristina Pfendler, J. Yoon, Gregory Taborn, M. Kuehn, P. Iannaccone (2000)
Nodal and Bone morphogenetic protein 5 interact in murine mesoderm formation and implantationgenesis, 28
L. Røste, E. Taubøll, A. Berner, J. Isojärvi, L. Gjerstad (2001)
Valproate, but not lamotrigine, induces ovarian morphological changes in Wistar rats.Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 52 6
C. Phiel, Fang Zhang, E. Huang, M. Guenther, M. Lazar, P. Klein (2001)
Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen*The Journal of Biological Chemistry, 276
J. Hunt, M. Petroff, T. Burnett (2000)
Uterine leukocytes: key players in pregnancy.Seminars in cell & developmental biology, 11 2
B. Mann, John Johnson, Kun He, R. Sridhara, S. Abraham, B. Booth, Leigh Verbois, D. Morse, Josephine Jee, Sarah Pope, R. Harapanhalli, R. Dagher, A. Farrell, R. Justice, R. Pazdur (2007)
Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell LymphomaClinical Cancer Research, 13
Annemieke Ruijter, A. Gennip, H. Caron, S. Kemp, A. Kuilenburg (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family.The Biochemical journal, 370 Pt 3
W. Whitten (1957)
The effect of progesterone on the development of mouse eggs in vitro.The Journal of endocrinology, 16 1
P. Marks, R. Breslow (2007)
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 25
B. Paria, Wen-ge Ma, Jian Tan, S. Raja, Sonjoy Das, S. Dey, B. Hogan (2001)
Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors.Proceedings of the National Academy of Sciences of the United States of America, 98 3
J. Wellstead, N. Bruce, A. Rahima (1989)
Effects of indomethacin on spacing of conceptuses within the uterine horn and on fetal and placental growth in the ratThe Anatomical Record, 225
OA Mohamed, M Jonnaert, C Labelle‐Dumais, K Kuroda, HJ Clarke, D Dufort (2005)
Uterine Wnt/β‐catenin signaling is required for implantation, 102
J. Daniel, J. Levy (1964)
ACTION OF PROGESTERONE AS A CLEAVAGE INHIBITOR OF RABBIT OVA IN VITRO.Journal of reproduction and fertility, 7
GD Niswender, TM Nett (1994)
The physiology of reproduction, 1
A McLaren, D Michie (1959)
The spacing of implantations in the mouse uterus, 6
L. Wise, K. Turner, J. Kerr (2007)
Assessment of developmental toxicity of vorinostat, a histone deacetylase inhibitor, in Sprague-Dawley rats and Dutch Belted rabbits.Birth defects research. Part B, Developmental and reproductive toxicology, 80 1
V. Richon, T. Sandhoff, R. Rifkind, P. Marks (2000)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.Proceedings of the National Academy of Sciences of the United States of America, 97 18
BACKGROUND: Histone deacetylase (HDAC) inhibitors have been shown to mediate the regulation of gene expression, induce cell growth, cell differentiation, and apoptosis of tumor cells. These compounds are now marketed or are in clinical development. One such HDAC inhibitor, vorinostat (suberoylanilide hydroxamic acid [SAHA], Zolinza), was assessed for its potential effects on fertility in Sprague–Dawley rats. METHODS: Female rats were administered oral dose levels of 0 (vehicle only), 15, 50, or 150 mg/kg/day of vorinostat for 14 days before cohabitation, during cohabitation, and through Gestation Day (GD) 7. In a separate study, male rats were administered oral dose levels of 0 (vehicle only), 20, 50, or 150 mg/kg/day for 10 weeks before cohabitation, during cohabitation, and until the day before scheduled sacrifice (approximately 14 weeks total). In both studies, % peri‐implantation loss and % postimplantation loss were evaluated on GD 15–17. Testicular weight and histomorphology, cauda epididymal sperm count, and sperm motility were evaluated in the male rat study at termination. RESULTS: There were treatment‐related decreases in body weight gain at 150 mg/kg/day in both studies. There were no effects on mating or fertility indices in either study. In the female study there were increased numbers of corpora lutea in all drug‐treated groups (only 1 or 2 affected dams in low and mid‐dose groups), and a marked increase in percent postimplantation loss only in the high‐dose group. No treatment‐related effects were observed on litter or sperm parameters of the male study. CONCLUSIONS: Vorinostat had no effects on mating or fertility in rats up to 150 mg/kg/day. There were no indications of reproductive toxicity in drug‐treated male rats. Increases in corpora lutea or resorptions were observed in treated female rats. Birth Defects Res (Part B) 80:1–8, 2007. © 2007 Wiley‐Liss, Inc.
Birth Defects Research Part B – Wiley
Published: Feb 1, 2008
Keywords: ; ; ; ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.